Clinical trial
Stage IV Colorectal CA ALIMTA
NCT00166465 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00166465 |
|---|---|
| Title | Stage IV Colorectal CA ALIMTA |
| Official title | A Phase I Dose-Finding Study and a Randomized Phase II Study of ALIMTA Plus Oxaliplatin Versus Oxaliplatin Plus 5-Fluorouracil and Leucovorin (FOLFOX 4 Regimen) in the First-Line Treatment of Patients With Locally Advanced Unresectable or Stage IV Colorectal Cancer |
| Lead sponsor | Mayo Clinic, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Locally Advanced Unresectable or Stage IV Colorectal Cancer |
| Intervention type | Drug |
| Interventions | ALIMTA plus Oxaliplatin versus Oxaliplatin plus 5-Fluorouracil and Leucovorin (FOLFOX 4 Regimen) |
| Enrollment | 200 |
| Start date | Aug 1, 2003 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Sep 14, 2005 |
| Last update posted | Mar 14, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: